Henry Meds and Liraglutide: How the GLP-1 Option Works

This PlexusDx Education Hub review focuses on a single GLP-1 compound — liraglutide — and how a telehealth program handles it, plus the genetics behind response. Browse all Peptides & GLP-1 education.

Independent editorial content. PlexusDx is not affiliated with Henry Meds, earns no commission, and prepared this review without the company’s participation.

Full head-to-head: PlexusDx vs Henry Meds →

This review narrows in on liraglutide specifically: where it sits within the GLP-1 class, how Henry Meds offers it, and the compounded-versus-branded distinction that shapes what you actually receive. Pricing detail is as verified July 20, 2026. The intent is to inform, not to steer a purchase.

Liraglutide’s place in the GLP-1 class

Liraglutide is a GLP-1 receptor agonist, the same broad mechanism that underlies semaglutide, though it is an earlier-generation molecule administered as a daily rather than weekly injection. That daily cadence and its longer clinical track record make it a distinct option within the class. Its pharmacology, like every GLP-1 agonist, works through the GLP-1 receptor pathway.

How Henry Meds offers liraglutide

Within Henry’s program, injectable liraglutide is published at $179/month month-to-month (verified July 20, 2026). As with its other medications, the provider evaluation is free, no membership fee applies, and nothing is billed until a licensed clinician writes the prescription. Confirm the current rate and availability on Henry Meds’s official website before making any decision.

How liraglutide compares within Henry’s ladder

Seeing liraglutide beside Henry’s other options clarifies where it fits on price and format. Here is the published ladder (verified July 20, 2026).

• Injectable compounded semaglutide (the flagship): $297/month month-to-month. Prepaying lowers it — the 6-month plan runs $1,482 ($247/month) and the 12-month plan runs $2,364 ($197/month). The widely advertised “$197/month” is that 12-month prepaid-in-full rate, not a month-to-month price.
• Oral (sublingual) semaglutide: $249/month month-to-month, with a $179/month tier.
• Oral tirzepatide: dissolving tablets only — Henry does not offer an injectable tirzepatide as of July 2026. It is sold as a 3-month supply at $1,047 ($891 paid in full); there is no published month-to-month tirzepatide rate.
• Liraglutide (injectable): $179/month month-to-month.
• Phentermine (oral): $149/month.

Compounded versus branded liraglutide

Branded liraglutide products are FDA-approved and dispensed as finished drugs, whereas a compounded version is prepared by a 503A pharmacy for an individual prescription. The molecule may be the same, but the regulatory pathway and product source differ, and that distinction is worth confirming with the program and your provider before you begin.

The genes beneath any GLP-1 response

Liraglutide acts on the GLP-1 receptor, but how forcefully that signal translates into appetite and energy change is shaped by variation you cannot see on a label. GLP1R encodes the receptor liraglutide binds, while FTO and MC4R shape the appetite and energy-balance biology that determines how much that binding translates into real-world change.

The same molecule can land very differently depending on the receptor it meets. PlexusDx runs its own Weight Management Protocols, offering Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection and Tirzepatide Oral — but it leads with the Precision Peptide Genetic Test, which reads 14 pathways, 49 peptides, 150+ genetic insights, including FTO and MC4R. Knowing that baseline first is what turns a prescription decision into an informed conversation with your provider.

Not affiliated: PlexusDx has no commercial relationship with Henry Meds, and this liraglutide-focused review was written independently of the company.

Related reading on PlexusDx:Discount Victoza, How To Buy Victoza, How To Get Victoza, Liraglutide vs Victoza.

To be clear: this article is educational and independent, and PlexusDx offers competing semaglutide and tirzepatide protocols. The Precision Peptide Genetic Test analyzes peptide-related pathways such as the GLP-1 receptor and does not predict response to liraglutide or any drug. Discuss options with a qualified provider before starting a protocol.

Before choosing a GLP-1 agonist, get your bearings: review the Weight Management Protocols, or take the Precision Peptide Genetic Test to read your GLP-1 pathway first.

Frequently Asked Questions About Henry Meds and Liraglutide

Does Henry Meds offer liraglutide?

Yes. Henry publishes injectable liraglutide at $179/month month-to-month as of July 20, 2026. The provider evaluation is free and nothing is charged until a licensed clinician issues a prescription. Availability and pricing can change, so confirm current details on Henry’s official website before enrolling.

How is liraglutide different from semaglutide?

Both are GLP-1 receptor agonists, but liraglutide is an earlier-generation molecule given daily, while semaglutide is typically weekly. They share the same receptor mechanism yet differ in cadence and clinical history. Which suits a given person is a clinical judgment, not something a webpage can decide.

Is Henry’s liraglutide the branded product?

Compounded telehealth programs generally supply patient-specific compounded formulations rather than FDA-approved branded drugs. The molecule can be identical, but the source and regulatory pathway differ. Confirm directly with Henry whether a given liraglutide prescription is compounded or branded before starting, and discuss the distinction with your provider.

Can genetics indicate whether liraglutide will work?

No. The Precision Peptide Genetic Test does not predict response to liraglutide or any drug. It reads pathway variants such as FTO that describe your baseline GLP-1 and appetite biology — useful context for a provider conversation, but never a forecast of a specific outcome.

This article lives in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.